Title

Safety and Effectiveness of Banked Cord Blood or Bone Marrow Stem Cells in Children With Cerebral Palsy (CP).
Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP)
  • Phase

    Phase 2
  • Study Type

    Interventional
  • Intervention/Treatment

    autologous mononuclear stem cell ...
  • Study Participants

    20
The purpose of this study is to compare the safety and effectiveness of two types of stem cells,(either banked cord blood or bone marrow), in children between the ages of 2 to 10 years with CP. 15 children with banked cord blood at CBR and 15 children without banked cord blood will be enrolled into the study. The study involves one baseline/treatment visit and 3 follow-up visits at 6 months, 12 months, and 2 years. Five children in each group will be randomized to a placebo control group at the baseline/treatment visit. Parents will not be told if their child received stem cells or a placebo until the 12 month follow-up visit. At that time parents may elect to have their child receive the stem cell treatment; either bone marrow harvest or umbilical cord blood if banked with CBR. All study visits will be conducted at the UTHealth Medical School and Children's Memorial Hermann Hospital in Houston, Texas.

As of 1/21/2014 we have met our enrollment limit for children without banked cord blood undergoing bone marrow harvest for stem cells.
Study Started
Nov 30
2013
Primary Completion
Feb 21
2018
Study Completion
Feb 21
2018
Results Posted
Nov 21
2022
Last Update
Nov 21
2022

Biological umbilical cord blood (hUCB) cells

Autologous umbilical cord blood banked with the Cord Blood Registry.

  • Other names: Autolgous Stem Cells

Drug Saline Infusion (Placebo)

A total of 10 children (5 from each cohort) will be randomized to a placebo infusion at the baseline visit and then have the opportunity to cross-over to stem cell treatment at the 1yr. visit.

Biological bone marrow derived mononuclear cells (BMMNCs)

Autologous stem cells from bone marrow harvest.

  • Other names: Autologous Stem Cells

umbilical cord blood (UCB) cells Experimental

Children who have banked UCB with CBR will receive an umbilical cord blood stem cell infusion at the baseline/treatment visit.

bone marrow-derived mononuclear cells (BMMNCs) Experimental

Children in the BMMNC group will undergo bone marrow harvest and stem cell infusion at the baseline/treatment visit.

saline infusion (placebo), then umbilical cord blood (UCB) cells Experimental

Five children in each group will be randomly assigned to receive an inactive substance (placebo) at the baseline/treatment visit. Parents will be given the opportunity to cross-over to either the umbilical cord blood or bone marrow harvest group at the one year visit.

saline infusion (placebo), then bone marrow-derived mononuclear cells (BMMNCs) Experimental

Criteria

Inclusion Criteria:

Children with diagnosis of Cerebral Palsy (spastic CP due to periventricular white matter damage or neonatal brain injury from perinatal stroke or intra-ventricular hemorrhage)
Gross Motor Function Classification Score level II-V
Ages 24 months to 10 years
English speaking, if verbal
Ability to travel to Houston for treatment and follow-up -

Exclusion Criteria:

Known history of:

Intractable seizures
Traumatic brain injury
Genetic disorder (as demonstrated by newborn screening or genetic diagnostic testing)
Recently treated or current infection
Renal insufficiency or altered renal function (as defined by serum creatinine > 1.5 mg/dl at screening)
Hepatic disease or altered liver function (as defined by SGPT > 150 U/L [non-contusion related], and/or T. Bilirubin >1.3 mg/dL at screening)
HIV+ (as demonstrated by positive blood test)
Immunosuppression (as defined by WBC <3,000 cells/ml at screening)
Infectious related neurological injury
Sensitivity to Ethylene Oxide (EtO) [found in fumigants and disinfectants]
If Athetoid CP diagnosis, other etiologies such as degenerative, mitochondrial, and metabolic disorders must be excluded, and the outcome assessments must be able to be conducted to assess for potential treatment effects
Normal brain MRI
Evidence of acute illness at the time of infusion, such as, but not limited to, fever (temperature > 37.5 C), vomiting, diarrhea, wheezing or crackles
Progressing neurological disease (as defined by Batten Disease, Leukodystrophies, Metabolic disorders, Mitochondrial disorders, Neurotransmitter disorders)
Microcephaly, macrocephaly, cortical malformations, genetic disorders of dysgenesis brain malformations due to infection or metabolic disorders
Pulmonary disease requiring ventilator support
If hUCB candidate, banked cord cells totaling <10 million/kg
If hUCB candidate, any positive maternal infectious disease test (Hepatitis A, Hepatitis B, HIV 1, HIV 2, HTLV 1, HTLV 2, and Syphilis)
If hUCB candidate, cord blood sample contamination
Participation in a concurrent intervention study
Unwillingness to return for follow-up visits
Contraindications to MRI
Any patient that the investigators feel in their opinion the study intervention is unlikely to benefit the patient will be a screen failure.
Any patients who are currently or has previously been enrolled in a clinical stem cell study.

Summary

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

Saline Infusion (Placebo)

All Events

Event Type Organ System Event Term Umbilical Cord Blood (UCB) Cells Bone Marrow-derived Mononuclear Cells (BMMNCs) Saline Infusion (Placebo)

Long-term Safety

Long-term safety as assessed by number of participants who developed new mass lesions or other pathological structural changes or had worsening neurological status

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

Saline Infusion (Placebo)

Safety as Assessed by Number of Participants With In-hospital Infusion Toxicity

In-hospital infusion toxicity includes hemodynamic, pulmonary, hepatic, renal, or neurologic complications.

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

Saline Infusion (Placebo)

Score on A Developmental NEuroPSYchological Assessment (NEPSY-II) - Learning and Memory Memory Subtest - Free/Cued

Scales scores from 1 to 19 with higher scores indicate better outcomes and lower scores indicate poorer outcomes.

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

4.0
score on a scale (Mean)
Standard Deviation: 0

Saline Infusion (Placebo)

Expressive and Receptive Vocabulary as Assessed by Score on the Peabody Picture Vocabulary Test (PPVT-4)

Standard score ranging from 20 to 160. Higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

80.0
score on a scale (Mean)
Standard Deviation: 26.87

Bone Marrow-derived Mononuclear Cells (BMMNCs)

85.0
score on a scale (Mean)
Standard Deviation: 13.34

Saline Infusion (Placebo)

89.0
score on a scale (Mean)
Standard Deviation: 0

Number of Participants With an Improvement in White Matter Integrity.

Number of participants with an improvement in white matter integrity as measured by diffusion tensor imaging (DTI) magnetic resonance imaging (MRI) reconstruction of corticospinal tract (CST) radial diffusivity (RD). Improvement is defined as radial diffusivity (RD) decreased in at least one corticospinal tract (CST) reconstruction.

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

Saline Infusion (Placebo)

Gross Motor Function Classification Score (GMFM-66)

Interval age adjusted scaled scores from 0 to 100 with 0 reflecting a child with low motor ability and 100 indicating high motor ability.

Umbilical Cord Blood (UCB) Cells

43.17
score on a scale (Mean)
Standard Deviation: 19.8

Bone Marrow-derived Mononuclear Cells (BMMNCs)

25.61
score on a scale (Mean)
Standard Deviation: 12.83

Saline Infusion (Placebo)

23.24
score on a scale (Mean)
Standard Deviation: 15.15

Gross Motor Function Classification Score (GMFM-66)

Interval age adjusted scaled scores from 0 to 100 with 0 reflecting a child with low motor ability and 100 indicating high motor ability.

Umbilical Cord Blood (UCB) Cells

36.5
score on a scale (Mean)
Standard Deviation: 24.1

Bone Marrow-derived Mononuclear Cells (BMMNCs)

25.95
score on a scale (Mean)
Standard Deviation: 13.88

Saline Infusion (Placebo)

Gross Motor Function Classification Score (GMFM-88)

Ordinal age adjusted scaled raw and percent scores from 0 to 100 with 0 reflecting a child with low motor ability and 100 indicating high motor ability.

Umbilical Cord Blood (UCB) Cells

50.67
score on a scale (Mean)
Standard Deviation: 37.5

Bone Marrow-derived Mononuclear Cells (BMMNCs)

24.72
score on a scale (Mean)
Standard Deviation: 20.06

Saline Infusion (Placebo)

18.06
score on a scale (Mean)
Standard Deviation: 21.56

Gross Motor Function Classification Score (GMFM-88)

Ordinal age adjusted scaled raw and percent scores from 0 to 100 with 0 reflecting a child with low motor ability and 100 indicating high motor ability.

Umbilical Cord Blood (UCB) Cells

34.77
score on a scale (Mean)
Standard Deviation: 40.38

Bone Marrow-derived Mononuclear Cells (BMMNCs)

25.92
score on a scale (Mean)
Standard Deviation: 19.83

Saline Infusion (Placebo)

Score on Vineland Adaptive Behavior Scales (VABS-2) - Communication

Standard score ranging from 20 to 140 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

79.0
score on a scale (Mean)
Standard Deviation: 16.09

Bone Marrow-derived Mononuclear Cells (BMMNCs)

67.56
score on a scale (Mean)
Standard Deviation: 21.04

Saline Infusion (Placebo)

52.86
score on a scale (Mean)
Standard Deviation: 15.95

Score on Vineland Adaptive Behavior Scales (VABS-2) - Communication

Standard score ranging from 20 to 140 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

64.4
score on a scale (Mean)
Standard Deviation: 18.96

Bone Marrow-derived Mononuclear Cells (BMMNCs)

62.23
score on a scale (Mean)
Standard Deviation: 20.79

Saline Infusion (Placebo)

Score on Vineland Adaptive Behavior Scales (VABS-2) - Daily Living

Standard score ranging from 20 to 140 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

67.0
score on a scale (Mean)
Standard Deviation: 16.09

Bone Marrow-derived Mononuclear Cells (BMMNCs)

57.44
score on a scale (Mean)
Standard Deviation: 9.58

Saline Infusion (Placebo)

49.14
score on a scale (Mean)
Standard Deviation: 8.95

Score on Vineland Adaptive Behavior Scales (VABS-2) - Daily Living

Standard score ranging from 20 to 140 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

63.0
score on a scale (Mean)
Standard Deviation: 23.16

Bone Marrow-derived Mononuclear Cells (BMMNCs)

52.54
score on a scale (Mean)
Standard Deviation: 13.2

Saline Infusion (Placebo)

Score on Vineland Adaptive Behavior Scales (VABS-2) - Social

Standard score ranging from 20 to 140 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

83.0
score on a scale (Mean)
Standard Deviation: 13

Bone Marrow-derived Mononuclear Cells (BMMNCs)

68.89
score on a scale (Mean)
Standard Deviation: 19.59

Saline Infusion (Placebo)

57.71
score on a scale (Mean)
Standard Deviation: 7.13

Score on Vineland Adaptive Behavior Scales (VABS-2) - Social

Standard score ranging from 20 to 140 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

65.0
score on a scale (Mean)
Standard Deviation: 16

Bone Marrow-derived Mononuclear Cells (BMMNCs)

60.75
score on a scale (Mean)
Standard Deviation: 16.84

Saline Infusion (Placebo)

Score on Vineland Adaptive Behavior Scales (VABS-2) - Motor

Standard score ranging from 20 to 140 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

58.67
score on a scale (Mean)
Standard Deviation: 15.5

Bone Marrow-derived Mononuclear Cells (BMMNCs)

43.0
score on a scale (Mean)
Standard Deviation: 11.75

Saline Infusion (Placebo)

38.5
score on a scale (Mean)
Standard Deviation: 14.62

Score on Vineland Adaptive Behavior Scales (VABS-2) - Motor

Standard score ranging from 20 to 140 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

52.33
score on a scale (Mean)
Standard Deviation: 16.8

Bone Marrow-derived Mononuclear Cells (BMMNCs)

40.67
score on a scale (Mean)
Standard Deviation: 11.24

Saline Infusion (Placebo)

Score on Pediatric Evaluation of Disability Inventory - Self-Care

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

35.4
score on a scale (Mean)
Standard Deviation: 12.29

Bone Marrow-derived Mononuclear Cells (BMMNCs)

43.31
score on a scale (Mean)
Standard Deviation: 13.04

Saline Infusion (Placebo)

27.36
score on a scale (Mean)
Standard Deviation: 9.35

Score on Pediatric Evaluation of Disability Inventory - Self-Care

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

36.28
score on a scale (Mean)
Standard Deviation: 13.97

Bone Marrow-derived Mononuclear Cells (BMMNCs)

37.13
score on a scale (Mean)
Standard Deviation: 16.35

Saline Infusion (Placebo)

Score on Pediatric Evaluation of Disability Inventory - Mobility

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

46.83
score on a scale (Mean)
Standard Deviation: 27.62

Bone Marrow-derived Mononuclear Cells (BMMNCs)

33.31
score on a scale (Mean)
Standard Deviation: 11.91

Saline Infusion (Placebo)

26.54
score on a scale (Mean)
Standard Deviation: 12.88

Score on Pediatric Evaluation of Disability Inventory - Mobility

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

39.66
score on a scale (Mean)
Standard Deviation: 36.36

Bone Marrow-derived Mononuclear Cells (BMMNCs)

34.16
score on a scale (Mean)
Standard Deviation: 14.8

Saline Infusion (Placebo)

Score on Pediatric Evaluation of Disability Inventory - Social

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

46.9
score on a scale (Mean)
Standard Deviation: 7.82

Bone Marrow-derived Mononuclear Cells (BMMNCs)

52.0
score on a scale (Mean)
Standard Deviation: 12.02

Saline Infusion (Placebo)

34.12
score on a scale (Mean)
Standard Deviation: 16.15

Score on Pediatric Evaluation of Disability Inventory - Social

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

44.54
score on a scale (Mean)
Standard Deviation: 9.29

Bone Marrow-derived Mononuclear Cells (BMMNCs)

47.32
score on a scale (Mean)
Standard Deviation: 14.82

Saline Infusion (Placebo)

Score on A Developmental NEuroPSYchological Assessment (NEPSY-II) - Learning and Memory Memory Subtest - Recall

Scales scores from 1 to 19 with higher scores indicate better outcomes and lower scores indicate poorer outcomes.

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

8.33
score on a scale (Mean)
Standard Deviation: 0.58

Saline Infusion (Placebo)

6.0
score on a scale (Mean)
Standard Deviation: 0

Expressive and Receptive Vocabulary as Assessed by Score on the Peabody Picture Vocabulary Test (PPVT-4)

Standard score ranging from 20 to 160. Higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

56.5
score on a scale (Mean)
Standard Deviation: 21.92

Bone Marrow-derived Mononuclear Cells (BMMNCs)

86.0
score on a scale (Mean)
Standard Deviation: 11.58

Saline Infusion (Placebo)

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Family

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

87.5
score on a scale (Mean)
Standard Deviation: 0

Bone Marrow-derived Mononuclear Cells (BMMNCs)

75.78
score on a scale (Mean)
Standard Deviation: 15.39

Saline Infusion (Placebo)

75.0
score on a scale (Mean)
Standard Deviation: 36.36

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Family

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

79.69
score on a scale (Mean)
Standard Deviation: 22.89

Bone Marrow-derived Mononuclear Cells (BMMNCs)

72.81
score on a scale (Mean)
Standard Deviation: 17.74

Saline Infusion (Placebo)

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Social

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

88.64
score on a scale (Mean)
Standard Deviation: 0

Bone Marrow-derived Mononuclear Cells (BMMNCs)

75.57
score on a scale (Mean)
Standard Deviation: 9.75

Saline Infusion (Placebo)

83.71
score on a scale (Mean)
Standard Deviation: 15.01

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Social

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

87.7
score on a scale (Mean)
Standard Deviation: 8.67

Bone Marrow-derived Mononuclear Cells (BMMNCs)

74.77
score on a scale (Mean)
Standard Deviation: 9.21

Saline Infusion (Placebo)

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Feelings

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

60.16
score on a scale (Mean)
Standard Deviation: 6.1

Saline Infusion (Placebo)

48.96
score on a scale (Mean)
Standard Deviation: 2.76

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Feelings

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

67.01
score on a scale (Mean)
Standard Deviation: 26.85

Bone Marrow-derived Mononuclear Cells (BMMNCs)

55.73
score on a scale (Mean)
Standard Deviation: 9.68

Saline Infusion (Placebo)

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Participation

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

72.73
score on a scale (Mean)
Standard Deviation: 0

Bone Marrow-derived Mononuclear Cells (BMMNCs)

56.82
score on a scale (Mean)
Standard Deviation: 8.25

Saline Infusion (Placebo)

56.82
score on a scale (Mean)
Standard Deviation: 17.71

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Participation

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

69.88
score on a scale (Mean)
Standard Deviation: 18.57

Bone Marrow-derived Mononuclear Cells (BMMNCs)

55.81
score on a scale (Mean)
Standard Deviation: 8.74

Saline Infusion (Placebo)

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Emotional

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

85.42
score on a scale (Mean)
Standard Deviation: 0

Bone Marrow-derived Mononuclear Cells (BMMNCs)

75.52
score on a scale (Mean)
Standard Deviation: 5.98

Saline Infusion (Placebo)

69.44
score on a scale (Mean)
Standard Deviation: 6.7

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Emotional

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

78.12
score on a scale (Mean)
Standard Deviation: 15.73

Bone Marrow-derived Mononuclear Cells (BMMNCs)

70.83
score on a scale (Mean)
Standard Deviation: 8.56

Saline Infusion (Placebo)

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Access

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

47.5
score on a scale (Mean)
Standard Deviation: 0

Bone Marrow-derived Mononuclear Cells (BMMNCs)

63.75
score on a scale (Mean)
Standard Deviation: 10.31

Saline Infusion (Placebo)

80.83
score on a scale (Mean)
Standard Deviation: 17.02

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Access

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

72.5
score on a scale (Mean)
Standard Deviation: 29.01

Bone Marrow-derived Mononuclear Cells (BMMNCs)

65.5
score on a scale (Mean)
Standard Deviation: 10.26

Saline Infusion (Placebo)

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Pain

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

3.13
score on a scale (Mean)
Standard Deviation: 0

Bone Marrow-derived Mononuclear Cells (BMMNCs)

40.63
score on a scale (Mean)
Standard Deviation: 20.53

Saline Infusion (Placebo)

35.94
score on a scale (Mean)
Standard Deviation: 19.88

Score on Cerebral Palsy Quality of Life Questionnaire (CPQOL) - Pain

Standard scores ranging from 0 to 100 with higher scores indicate a child with a higher level of functioning and lower scores indicate a lower level of functioning.

Umbilical Cord Blood (UCB) Cells

22.39
score on a scale (Mean)
Standard Deviation: 20.82

Bone Marrow-derived Mononuclear Cells (BMMNCs)

34.38
score on a scale (Mean)
Standard Deviation: 21.26

Saline Infusion (Placebo)

Visual-Spatial Processing as Assessed by Score on the Motor-Free Visual Perception Test (MVPT-3)

Standard scores ranging from 55 to 145 with higher scores indicating better outcomes and lower scores poorer outcomes.

Umbilical Cord Blood (UCB) Cells

55.0
score on a scale (Mean)
Standard Deviation: 0

Bone Marrow-derived Mononuclear Cells (BMMNCs)

55.0
score on a scale (Mean)
Standard Deviation: 0

Saline Infusion (Placebo)

Score on A Developmental NEuroPSYchological Assessment (NEPSY-II) - Learning and Memory Memory Subtest - Recall

Scales scores from 1 to 19 with higher scores indicate better outcomes and lower scores indicate poorer outcomes.

Umbilical Cord Blood (UCB) Cells

6.0
score on a scale (Mean)
Standard Deviation: 0

Bone Marrow-derived Mononuclear Cells (BMMNCs)

5.0
score on a scale (Mean)
Standard Deviation: 1

Saline Infusion (Placebo)

Visual-Spatial Processing as Assessed by Score on the Motor-Free Visual Perception Test (MVPT-3)

Standard scores ranging from 55 to 145 with higher scores indicating better outcomes and lower scores poorer outcomes.

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

63.0
score on a scale (Mean)
Standard Deviation: 11.31

Saline Infusion (Placebo)

Score on A Developmental NEuroPSYchological Assessment (NEPSY-II) - Learning and Memory Memory Subtest - Free/Cued

Scales scores from 1 to 19 with higher scores indicate better outcomes and lower scores indicate poorer outcomes.

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

5.67
score on a scale (Mean)
Standard Deviation: 1.53

Saline Infusion (Placebo)

6.0
score on a scale (Mean)
Standard Deviation: 0

Total

20
Participants

Age, Continuous

5.6
years (Mean)
Standard Deviation: 2.85

Age, Categorical

Ethnicity (NIH/OMB)

Race (NIH/OMB)

Region of Enrollment

Sex: Female, Male

Blinded Phase

Umbilical Cord Blood (UCB) Cells

Bone Marrow-derived Mononuclear Cells (BMMNCs)

Saline Infusion (Placebo), Then Umbilical Cord Blood (UCB) Cells

Saline Infusion (Placebo), Then Bone Marrow-derived Mononuclear Cells (BMMNCs)

Unblinded Phase - Placebo Arm Crossover

Saline Infusion (Placebo), Then Umbilical Cord Blood (UCB) Cells

Saline Infusion (Placebo), Then Bone Marrow-derived Mononuclear Cells (BMMNCs)